Back to Search
Start Over
The IL-3Rα-Targeted Drug SL-401 Selectively Kills Blastic Plasmacytoid Dendritic Cell Neoplasm Cells
- Source :
- Blood; November 2011, Vol. 118 Issue: 21 p2588-2588, 1p
- Publication Year :
- 2011
-
Abstract
- Frankel: Stemline Therapeutics: Patents & Royalties, Research Funding. Jacobson:Stemline Therapeutics, Inc: Employment, stock Options. Cirrito:Stemline Therapeutics, Inc: Employment, Equity Ownership, Patents & Royalties. Brooks:Stemline Therapeutics, Inc: Employment, equity options.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 118
- Issue :
- 21
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs52984312
- Full Text :
- https://doi.org/10.1182/blood.V118.21.2588.2588